UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

The American journal of pathology, 2016-03, Vol.186 (3), p.652-658

2016

Link zum Volltext

Verfügbarkeit prüfen

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

Emerging infectious diseases, 2016-10, Vol.22 (10), p.1824-1826

2016

Link zum Volltext

Verfügbarkeit prüfen

Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

Clinical infectious diseases, 2014-11, Vol.59 (9), p.1225-1233

2014

Link zum Volltext

Verfügbarkeit prüfen

Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

Journal of Virology, 2009-02, Vol.83 (3), p.1492-1500

2009

Link zum Volltext

Verfügbarkeit prüfen

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model

Antiviral research, 2018-06, Vol.154, p.149-157

2018

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease

PloS one, 2013-09, Vol.8 (9), p.e74905

2013

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

The Journal of infectious diseases, 2009-08, Vol.200 (3), p.439-447

2009

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of Middle East respiratory syndrome coronavirus (MERS‐CoV) antibodies in dromedary camels in Israel

Zoonoses and public health, 2018-09, Vol.65 (6), p.749-754

2018

Link zum Volltext

Verfügbarkeit prüfen

Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014

Emerging infectious diseases, 2016-08, Vol.22 (8), p.1395-1402

2016

Link zum Volltext

Verfügbarkeit prüfen

A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

Journal of Virology, 2013-10, Vol.87 (20), p.10955-10967

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security

Emerging infectious diseases, 2017-12, Vol.23 (13), p.S121-S125

2017

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice

PloS one, 2012-12, Vol.7 (12), p.e51485-e51485

2012

Link zum Volltext

Verfügbarkeit prüfen

Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice

Journal of Virology, 2010-01, Vol.84 (2), p.1148-1157

2010

Link zum Volltext

Verfügbarkeit prüfen

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

Nature immunology, 2000-11, Vol.1 (5), p.398-401

2000

Link zum Volltext

Verfügbarkeit prüfen

RSV Growth and Quantification by Microtitration and qRT-PCR Assays

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1442, p.13

2016

Link zum Volltext

Verfügbarkeit prüfen

Health care worker contact with MERS patient, Saudi Arabia

Emerging infectious diseases, 2014-12, Vol.20 (12), p.2148-2151

2014

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

Journal of Virology, 2010-09, Vol.84 (18), p.9632-9636

2010

Link zum Volltext

Verfügbarkeit prüfen

Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014

Emerging infectious diseases, 2016-07, Vol.22 (7), p.1162-1168

2016

Link zum Volltext

Verfügbarkeit prüfen

Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice

PloS one, 2013-12, Vol.8 (12), p.e83075-e83075

2013

Link zum Volltext

Verfügbarkeit prüfen

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children

The New England journal of medicine, 2015-02, Vol.372 (9), p.835-845

2015

Link zum Volltext

Verfügbarkeit prüfen

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection

Vaccines (Basel), 2017-07, Vol.5 (3), p.16

2017

Link zum Volltext

Verfügbarkeit prüfen

Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014

Emerging infectious diseases, 2015-07, Vol.21 (7), p.1128-1134

2015

Link zum Volltext

Verfügbarkeit prüfen

Progress and Challenges in RSV Prophylaxis and Vaccine Development

The Journal of infectious diseases, 2013-12, Vol.208 (suppl 3), p.S177-S183

Haynes, Lia M.

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(73)
Buchkapitel
(2)

Sprache

Englisch
(75)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(46)
Animals
(34)
Female
(31)
Humans
(31)
Immunology
(26)
Mice
(24)
Infectious Diseases
(22)
Respiratory Syncytial Virus
(19)
Male
(18)
Mice, Inbred Balb C
(17)
Virology
(17)
Microbiology
(15)
Adult
(14)
Viruses
(14)
Biological And Medical Sciences
(13)
Coronavirus Infections - Epidemiology
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Respiratory Syncytial Virus Infections - Immunology
(13)
Antibodies, Viral - Blood
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi

Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model

Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

The prevalence of Middle East respiratory syndrome coronavirus (MERS‐CoV) antibodies in dromedary camels in Israel

Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014

A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice

Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

RSV Growth and Quantification by Microtitration and qRT-PCR Assays

Health care worker contact with MERS patient, Saudi Arabia

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014

Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection

Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014

Progress and Challenges in RSV Prophylaxis and Vaccine Development

Suchergebnisse filtern